— Know what they know.
Not Investment Advice

LENZ NASDAQ

LENZ Therapeutics, Inc.
1W: -8.7% 1M: -38.3% 3M: -36.1% YTD: -77.6% 1Y: -92.7%
$3.58
-0.21 (-5.54%)
 
Weekly Expected Move ±8.8%
$3 $3 $4 $4 $4
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 29 · $112.2M mcap · 27M float · 3.00% daily turnover · Short 43% of daily vol

📊 Key Metrics

TTM
$21M
Revenue
+329.5% YoY
$-126M
Net Income
-140.5% YoY
$-114M
Free Cash Flow
-138.9% YoY
94.9%
Gross Margin
-622.9%
Op. Margin
-581.8%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-59.2%
ROA-55.5%
ROIC17313.3%

Valuation

P/E-0.9
P/B0.5
EV/EBITDA0.3

Leverage

Debt/Equity0.00
Current Ratio13.55
Interest Cov.0.0x

Quality Scores

Piotroski F3/9
Altman Z3.82
Beneish M-2.88

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms